This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1zeg

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1zeg.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1zeg.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1zeg| PDB=1zeg | SCENE= }}
{{STRUCTURE_1zeg| PDB=1zeg | SCENE= }}
-
'''STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL'''
+
===STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL===
-
==Overview==
+
<!--
-
Insulin's natural tendency to form dimers and hexamers is significantly reduced in a mutant insulin B28 Pro --&gt; Asp, which has been designed as a monomeric, rapid-acting hormone for therapeutic purposes. This molecule can be induced to form zinc hexamers in the presence of small phenolic derivatives which are routinely used as antimicrobial agents in insulin preparations. Two structures of B28 Asp insulin have been determined from crystals grown in the presence of phenol and m-cresol. In these crystals, insulin exists as R6 zinc hexamers containing a number of phenol or m-cresol molecules associated with aromatic side chains at the dimer-dimer interfaces. At the monomer-monomer interfaces, the B28 Pro --&gt; Asp mutation leads to increased conformational flexibility in the B chain C termini, resulting in the loss of important intermolecular van der Waals contacts, thus explaining the monomeric character of B28 Asp insulin. The structure of a cross-linked derivative of B28 Asp insulin, containing an Ala-Lys dipeptide linker between residues B30 Ala and A1 Gly, has also determined. This forms an R6 zinc hexamer containing several m-cresol molecules. Of particular interest in this structure are two m-cresol molecules whose binding disrupted the beta-strand in one of the dimers. This observation suggests that the cross-link introduces mechanical strain on the B chain C terminus, thereby weakening the monomer-monomer interactions.
+
The line below this paragraph, {{ABSTRACT_PUBMED_9708987}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 9708987 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_9708987}}
==About this Structure==
==About this Structure==
Line 34: Line 38:
[[Category: Insulin mutant]]
[[Category: Insulin mutant]]
[[Category: Metabolic role]]
[[Category: Metabolic role]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 17:31:35 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 10:29:47 2008''

Revision as of 07:29, 28 July 2008

Image:1zeg.png

Template:STRUCTURE 1zeg

STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL

Template:ABSTRACT PUBMED 9708987

About this Structure

1ZEG is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues., Whittingham JL, Edwards DJ, Antson AA, Clarkson JM, Dodson GG, Biochemistry. 1998 Aug 18;37(33):11516-23. PMID:9708987

Page seeded by OCA on Mon Jul 28 10:29:47 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1zeg"
Personal tools